Novo Nordisk to double staff at China R&D centre
This article was originally published in Scrip
Executive Summary
Novo Nordisk has become the latest multinational to post a vote of confidence in China's research capabilities with the announcement that it is to double staff numbers at an existing R&D facility in Beijing.